1610P Humoral immune response to COVID-19 vaccination in patients with cancer: The ANRS0001S COV-POPART study

por Luong Nguyen, L.B., Chalouni, M., Loubet, P., Dohollou, N., Tredan, O., Veyri, M., Maakaroun-Vermesse, Z., Ben Ghezala, I., Fourn, E., Merrien, D., Cracowski, C., Barquin, A., Levier, A., Wittkop, L., Launay, O., Blay, J-Y., Spano, J-P.
Publicado 2022

Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group

por Ray-Coquard, I, Weber, B, Cretin, J, Haddad-Guichard, Z, Lévy, E, Hardy-Bessard, A C, Gouttebel, M C, Geay, J-F, Aleba, A, Orfeuvre, H, Agostini, C, Provencal, J, Ferrero, J M, Fric, D, Dohollou, N, Paraiso, D, Salvat, J, Pujade-Lauraine, É
Publicado 2009